ST-02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ST-02, covering 2025-09-15 to 2025-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma [Phase 2, Phase 3]